WEVEE VLP
Alternative Names: VRC-WEVVLP073-00-VP; Western-Eastern-Venezuelan equine encephalitis VLP vaccine - Emergent BioSolutions; WEVEE virus-like particles vaccine- Emergent BioSolutionsLatest Information Update: 28 Mar 2024
At a glance
- Originator National Institute of Allergy and Infectious Diseases
- Class Protein vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Eastern equine encephalomyelitis; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for phase-I development in Eastern-equine-encephalomyelitis(Prevention, In volunteers) in USA (IM, Injection)
- 28 Mar 2024 No recent reports of development identified for phase-I development in Venezuelan-equine-encephalomyelitis(Prevention) in USA (IM, Injection)
- 28 Mar 2024 No recent reports of development identified for phase-I development in Western-equine-encephalitis-virus-infections(Prevention) in USA (IM, Injection)